Koninklijke Vopak N.V. (VOPKF)

Intra-Cellular Therapies Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	99.6	94.2	197	33.8	73.4	68.3
Trading Asset Securities	-	10.6	-	-	-	-
Cash & Short-Term Investments	99.6	104.8	197	33.8	73.4	68.3
Cash Growth	3.32%	-46.80%	482.84%	-53.95%	7.47%	-27.73%
Accounts Receivable	285.6	141	128.7	134	109.8	101.5
Other Receivables	3.6	214.4	229.8	190.3	153.4	174.6
Receivables	301.6	361	380.1	326.2	264	276.1
Prepaid Expenses	40.2	35.7	29.1	37.1	30	36.6
Other Current Assets	32.3	33	38.8	123.5	200.3	5.1
Total Current Assets	473.7	534.5	645	520.6	567.7	386.1
Property, Plant & Equipment	3,649	3,805	3,744	4,195	4,475	4,431
Long-Term Investments	2,142	2,046	1,889	1,972	1,667	1,356
Goodwill	-	6.6	6.3	6.5	6.2	38.5
Other Intangible Assets	110.2	96.1	95.8	103.2	104.8	109.1
Long-Term Accounts Receivable	100.1	120.2	115.9	126.1	127.6	28.6
Long-Term Deferred Tax Assets	38.6	39.5	38.8	8.7	50.6	43.2
Other Long-Term Assets	19.2	21.6	20.5	23.2	43	15.1
Total Assets	6,677	6,802	6,654	6,999	7,087	6,499
Accounts Payable	323.1	124.4	140.8	77.1	70.1	51.4
Accrued Expenses	0.1	202.9	166.8	128.6	124.4	164.9
Short-Term Debt	104.8	112.3	-	277.9	464.6	214.3
Current Portion of Long-Term Debt	63.3	279.2	226	419	0.3	127.9
Current Portion of Leases	32.6	33.3	31.4	36.2	35.2	30.7
Current Income Taxes Payable	32.6	43	31.9	51.4	47.9	55.5
Current Unearned Revenue	-	47.5	30.6	24	32	18.6
Other Current Liabilities	58.9	33.1	41.3	148.6	185.9	170
Total Current Liabilities	615.4	875.7	668.8	1,163	960.4	833.3
Long-Term Debt	2,043	1,725	1,644	1,663	1,822	1,616
Long-Term Leases	592.2	618.1	608.3	688.8	676.1	668.5
Long-Term Deferred Tax Liabilities	255.4	267.7	252.7	251.5	217.4	183.3
Other Long-Term Liabilities	70.5	64.1	94.8	79.1	30.2	41.9
Total Liabilities	3,582	3,558	3,278	3,853	3,741	3,392
Common Stock	58.9	58.9	62.9	62.9	62.9	62.9
Additional Paid-In Capital	-	-	194.4	194.4	194.4	194.4
Retained Earnings	3,293	3,161	3,068	2,771	3,104	3,036
Treasury Stock	-107.9	-25.3	-20.5	-12.9	-15.7	-15
Comprehensive Income & Other	-273.6	-97.5	-81.8	-30.9	-157	-317
Total Common Equity	2,970	3,097	3,223	2,985	3,189	2,961
Minority Interest	124.7	147.2	153.2	161.6	156.9	144.9
Shareholders' Equity	3,095	3,244	3,376	3,146	3,346	3,106
Total Liabilities & Equity	6,677	6,802	6,654	6,999	7,087	6,499
Total Debt	2,835	2,768	2,510	3,085	2,999	2,658
Net Cash (Debt)	-2,736	-2,663	-2,313	-3,051	-2,925	-2,589
Net Cash Per Share	-23.29	-22.03	-18.39	-24.30	-23.29	-20.44
Filing Date Shares Outstanding	114.98	117.11	125.15	125.42	125.35	125.39
Total Common Shares Outstanding	114.98	117.11	125.15	125.42	125.35	125.39
Working Capital	-141.7	-341.2	-23.8	-642.2	-392.7	-447.2
Book Value Per Share	25.83	26.44	25.76	23.80	25.44	23.62
Tangible Book Value	2,860	2,994	3,121	2,875	3,078	2,814
Tangible Book Value Per Share	24.87	25.57	24.94	22.92	24.55	22.44
Land	-	34.7	25.2	25.6	23.8	39.2
Buildings	-	317.3	297.7	363.6	348.4	315.7
Machinery	-	160.6	144.7	164.5	156.2	132.3
Construction In Progress	-	354.9	325.6	369.9	357.5	709.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.